Benzydamine inhibits the release of tumor necrosis factor-α and monocyte chemotactic protein-1 by Candida albicans-stimulated human peripheral blood cells

International Journal of Clinical and Laboratory Research

Volumn 27, Issue 2, 1997, Pages 118-122

  Sironi, M ^a   Milanese, C ^b   Vecchi, A ^a   Polenzani, L ^b   Guglielmotti, A ^b   Coletta, I ^b   Landolfi, C ^b   Soldo, L ^b   Mantovani, A ^a   Pinza, M ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b Università Politecnica delle Marche ACRAF Gruppo Angelini   (Italy)

Author keywords

Antiinflammatory drug; Candida albicans; Chemokines; Interleukins; Vaginitis

Indexed keywords

BACTERIA (MICROORGANISMS); CANDIDA; CANDIDA ALBICANS;

EID: 8544226909     PISSN: 09405437     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02912445     Document Type: Article

References (17)

1. Cioli V, Corradino C, Scorza Barcellona P. Review of pharmacological data on benzydamine. Int J Tissue React 1985; 7: 205.
2. Mahon WA, De Gregorio M. Benzydamine: a critical review of clinical data. Int J Tissue React 1985; 7:229.
3. Bremond A. Clinical evaluation of benzydamine for treatment of vaginitis: results of a randomized study with emphasis on functional symptoms. Int J Tissue React 1987; 9:147.
4. Jensen J, Warner T, Balish E. Resistance of SCID mice to C. albicans administered intravenously or colonizing the gut: role of polymorphonuclear leukocytes and macrophages. J Infect Dis 1993; 167:912.
5. 2 formation in macrophages interacting with certain bacteria. Eur J Biochem 1991; 200:699.
6. Djeu JY, Blanchard DK, Halkias D, Friedman H. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-α and tumor necrosis factor. J Immunol 1986; 137:2980.
7. Cassone A, Conti S, De Bernardis F, Polonelli L. Antibodies, killer toxins and antifungal immunoprotection: a lesson from nature? Immunol Today. In press.
8. Romani L, Mencacci A, Cenci E, Spaccapelo R, Toniatti C, Puccetti P, Bistoni F, Poli V. Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J Exp Med 1996; 183:1345.
9. Garner ER, Rubanovice K, Sawyer RT, Hudson JA. Secretion of TNFαby alveolar macrophages in response to Candida albicans mannan. J Leukoc Biol 1994; 55:161.
10. Sironi M, Pozzi P, Polentarutti N, Benigni F, Coletta I, Guglielmotti A, Milanese C, Ghezzi P, Vecchi A, Pinza M, Mantovani A. Inhibition of inflammatory cytokine production and protection against endotoxin toxicity by benzydamine. Cytokine 1996; 8:710.
11. Marconi P, Scaringi L, Tissi L, Boccanera M, Bistoni F, Bonmassar E, Cassone A. Induction of natural killer activity by inactivated Candida albicans in mice. Infect Immun 1985; 50:297.
12. Djeu JY, Blanchard DK, Richards AL, Friedman H. Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes. J Immunol 1988; 141:4047.
13. Sironi M, Breviario F, Proserpio P, Biondi A, Vecchi A, Van Damme J, Dejana E, Mantovani A. IL-1 stimulates IL-6 production in endothelial cells. J Immunol 1989; 142:549.
14. Peri G, Milanese C, Matteucci C, Ruco L, Zhou D, Sozzani S, Coletta I, Mantovani A. A new monoclonal antibody (5D3-F7) which recognizes human monocyte-chemotactic protein-1 but not related chemokines. Development of a sandwich ELISA and in situ detection of producing cells. J Immunol Methods 1994; 174:249.
15. Bernasconi S, Cinque P, Peri G, Sozzani S, Crociati A, Lazzarin A, Poli G, Mantovani A. Selective elevation of monocyte chemotactic protein-1 (MCP-1) in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis. J Infect Dis. 1996; 174:1098.
16. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 1991; 9:617.
17. Sobel J. Genital candidiasis. In: Holmes KK et al., eds. Sexually transmitted diseases. New York: McGraw-Hill; 1990.